190 related articles for article (PubMed ID: 28344172)
1. Physicochemical attributes and dissolution testing of ophthalmic ointments.
Bao Q; Jog R; Shen J; Newman B; Wang Y; Choi S; Burgess DJ
Int J Pharm; 2017 May; 523(1):310-319. PubMed ID: 28344172
[TBL] [Abstract][Full Text] [Related]
2. In vitro and ex vivo correlation of drug release from ophthalmic ointments.
Bao Q; Newman B; Wang Y; Choi S; Burgess DJ
J Control Release; 2018 Apr; 276():93-101. PubMed ID: 29518465
[TBL] [Abstract][Full Text] [Related]
3. In vitro release testing method development for ophthalmic ointments.
Bao Q; Shen J; Jog R; Zhang C; Newman B; Wang Y; Choi S; Burgess DJ
Int J Pharm; 2017 Jun; 526(1-2):145-156. PubMed ID: 28461266
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
Bao Q; Burgess DJ
Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
[TBL] [Abstract][Full Text] [Related]
5. Influence of in vitro release methods on assessment of tobramycin ophthalmic ointments.
Patere S; Newman B; Wang Y; Choi S; Mekjaruskul C; Jay M; Lu X
Int J Pharm; 2020 Nov; 590():119938. PubMed ID: 33011250
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical attributes of white petrolatum from various sources used for ophthalmic ointment formulations.
Bao Q; Morales-Acosta MD; Burgess DJ
Int J Pharm; 2020 Jun; 583():119381. PubMed ID: 32360506
[TBL] [Abstract][Full Text] [Related]
7. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments.
Xu X; Al-Ghabeish M; Rahman Z; Krishnaiah YS; Yerlikaya F; Yang Y; Manda P; Hunt RL; Khan MA
Int J Pharm; 2015 Sep; 493(1-2):412-25. PubMed ID: 26231106
[TBL] [Abstract][Full Text] [Related]
8. Impact of active pharmaceutical ingredient variables and oleaginous base on the in vitro drug release from ophthalmic ointments: An investigation using dexamethasone as a model drug.
Mekjaruskul C; O'Reilly Beringhs A; Qin B; Wang Y; Lu X
Int J Pharm; 2024 Jun; 658():124184. PubMed ID: 38692497
[TBL] [Abstract][Full Text] [Related]
9. Influence of Manufacturing Process Variables on the Properties of Ophthalmic Ointments of Tobramycin.
Patere S; Newman B; Wang Y; Choi S; Vora S; Ma AWK; Jay M; Lu X
Pharm Res; 2018 Jul; 35(9):179. PubMed ID: 30046909
[TBL] [Abstract][Full Text] [Related]
10. Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments.
Dong Y; Qu H; Pavurala N; Wang J; Sekar V; Martinez MN; Fahmy R; Ashraf M; Cruz CN; Xu X
Int J Pharm; 2018 Jun; 544(1):254-264. PubMed ID: 29684560
[TBL] [Abstract][Full Text] [Related]
11. Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.
Mekjaruskul C; O'Reilly Beringhs A; Qin B; Wang Y; Chowdhury P; Lu X
Pharm Res; 2023 Sep; 40(9):2239-2251. PubMed ID: 37679656
[TBL] [Abstract][Full Text] [Related]
12. Development of an Ointment Formulation Using Hot-Melt Extrusion Technology.
Bhagurkar AM; Angamuthu M; Patil H; Tiwari RV; Maurya A; Hashemnejad SM; Kundu S; Murthy SN; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):158-66. PubMed ID: 26628438
[TBL] [Abstract][Full Text] [Related]
13. Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38.
Cavet ME; Glogowski S; Lowe ER; Phillips E
J Ocul Pharmacol Ther; 2019 Jun; 35(5):291-300. PubMed ID: 30907685
[No Abstract] [Full Text] [Related]
14. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
15. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
[TBL] [Abstract][Full Text] [Related]
16. Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.
Siemiradzka W; Dolińska B; Ryszka F
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549368
[TBL] [Abstract][Full Text] [Related]
17. Influence of plasma on the physical properties of ointments with quercetin.
Szulc-Musioł B; Dolińska B; Kołodziejska J; Ryszka F
Acta Pharm; 2017 Dec; 67(4):569-578. PubMed ID: 29337672
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of drug release from ointments: Role of transient-boundary layer.
Xu X; Al-Ghabeish M; Krishnaiah YS; Rahman Z; Khan MA
Int J Pharm; 2015 Oct; 494(1):31-9. PubMed ID: 26241753
[TBL] [Abstract][Full Text] [Related]
19. Loteprednol etabonate ophthalmic gel 0.5%: a review of its use in post-operative inflammation and pain following ocular surgery.
Lyseng-Williamson KA
Drugs; 2013 Jun; 73(9):949-58. PubMed ID: 23740411
[TBL] [Abstract][Full Text] [Related]
20. Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment-Distribution of Hydrocarbon.
Ashizuka Y; Otoguro S; Horisawa E
Chem Pharm Bull (Tokyo); 2021; 69(4):352-359. PubMed ID: 33790080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
